Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹776.6
  • Day's High
  • ₹793
₹ 784.7
  • 52-w low
  • ₹280
  • 52-w high
  • ₹838.6
784.7
  • Day's open
    ₹779.95
  • Previous close
    ₹775.1
  • VWAP
    ₹784.32
  • Lower price band
    ₹627.8
  • Upper price band
    ₹941.6

Today's Market Action

The last traded share price of Strides Pharma Science Ltd was 784.70 up by 1.41% on the NSE. Its last traded stock price on BSE was 782.60 up by 1.16%. The total volume of shares on NSE and BSE combined was 181,338 shares. Its total combined turnover was Rs 14.22 crores.

Medium and Long Term Market Action

Strides Pharma Science Ltd hit a 52-week high of 838.6 on 20-02-2024 and a 52-week low of 280 on 29-03-2023. The stock price of Strides Pharma Science Ltd is down by -2% over the last one month. It is up by 176.3% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 7211

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Strides Pharma Science Ltd?

What is the Market Cap of Strides Pharma Science Ltd?

What is PE Ratio of Strides Pharma Science Ltd?

What is PB Ratio of Strides Pharma Science Ltd?

What is the CAGR of Strides Pharma Science Ltd?

How to Buy Strides Pharma Science Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Shareholder Pedigree
    The company has a solid long term shareholder base which reduces the degree of speculation and volatility in the stock. This works well for long term equity shareholders.

Cons

  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 18.64% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 0.56 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.94. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 219 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 67% of the total company's shareholding which can have a significantly negative impact on stock.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(29/03/2024)
Stock Valuation
Yellow line
84
100.00%
100.00% People are bullish about Strides Pharma Science Ltd
0.00%
0.00 % People are bearish about Strides Pharma Science Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Strides Pharma Science Ltd

784.70 +10.90 (1.41%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %